Macular Neovascularization Secondary to Age-Related Macular Degeneration

Ophthalmology
1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

4D Molecular Therapeutics
1 program
1
4D-150 IVTPhase 31 trial
Active Trials
NCT06864988Recruiting480Est. Jun 2028

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
4D Molecular Therapeutics4D-150 IVT

Clinical Trials (1)

Total enrollment: 480 patients across 1 trials

NCT068649884D Molecular Therapeutics4D-150 IVT

4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Start: Mar 2025Est. completion: Jun 2028480 patients
Phase 3Recruiting

Related Jobs in Ophthalmology

Lead Data Manager

Genomics
Remote
4h ago

Cleanroom and Laboratory Technician

SAB BIO
4h ago

Product Specialist

Johnson & Johnson
Hangzhou, Zhejiang, China
20h ago

BM 喀什 PSR HY

Johnson & Johnson
Urumqi, Xinjiang, China
20h ago

Site Delivery Leader MLL

Johnson & Johnson
Gent, East Flanders, Belgium
20h ago

Clinical Operations Manager

Johnson & Johnson
Irvine, California, United States of America
20h ago
$117K - $201K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials targeting 480 patients
1 companies competing in this space

Related Indications

Myopia(127)Cataract(116)Open-Angle Glaucoma(102)Glaucoma(92)Dry Eye(74)Age-Related Macular Degeneration(73)Dry Eye Disease(43)Neovascular Age-related Macular Degeneration(40)Macular Degeneration(37)Diabetic Retinopathy(25)